JP2019519484A5 - - Google Patents

Download PDF

Info

Publication number
JP2019519484A5
JP2019519484A5 JP2018557818A JP2018557818A JP2019519484A5 JP 2019519484 A5 JP2019519484 A5 JP 2019519484A5 JP 2018557818 A JP2018557818 A JP 2018557818A JP 2018557818 A JP2018557818 A JP 2018557818A JP 2019519484 A5 JP2019519484 A5 JP 2019519484A5
Authority
JP
Japan
Prior art keywords
acetamide
pyrazol
sulfamoylphenyl
chlorophenyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018557818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019519484A (ja
JP7033079B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/059882 external-priority patent/WO2017191000A1/en
Publication of JP2019519484A publication Critical patent/JP2019519484A/ja
Publication of JP2019519484A5 publication Critical patent/JP2019519484A5/ja
Priority to JP2021198484A priority Critical patent/JP7104232B2/ja
Application granted granted Critical
Publication of JP7033079B2 publication Critical patent/JP7033079B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018557818A 2016-05-03 2017-04-26 芳香族スルホンアミド誘導体 Active JP7033079B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021198484A JP7104232B2 (ja) 2016-05-03 2021-12-07 芳香族スルホンアミド誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16167996 2016-05-03
EP16167996.4 2016-05-03
PCT/EP2017/059882 WO2017191000A1 (en) 2016-05-03 2017-04-26 Aromatic sulfonamide derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021198484A Division JP7104232B2 (ja) 2016-05-03 2021-12-07 芳香族スルホンアミド誘導体

Publications (3)

Publication Number Publication Date
JP2019519484A JP2019519484A (ja) 2019-07-11
JP2019519484A5 true JP2019519484A5 (enExample) 2020-06-11
JP7033079B2 JP7033079B2 (ja) 2022-03-09

Family

ID=55910814

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018557818A Active JP7033079B2 (ja) 2016-05-03 2017-04-26 芳香族スルホンアミド誘導体
JP2021198484A Active JP7104232B2 (ja) 2016-05-03 2021-12-07 芳香族スルホンアミド誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021198484A Active JP7104232B2 (ja) 2016-05-03 2021-12-07 芳香族スルホンアミド誘導体

Country Status (42)

Country Link
US (2) US10844016B2 (enExample)
EP (2) EP3458443B1 (enExample)
JP (2) JP7033079B2 (enExample)
KR (1) KR102388962B1 (enExample)
CN (3) CN109415321B (enExample)
AR (1) AR108356A1 (enExample)
AU (1) AU2017260125B2 (enExample)
CL (1) CL2018003135A1 (enExample)
CO (1) CO2018011935A2 (enExample)
CR (1) CR20180528A (enExample)
CU (1) CU24516B1 (enExample)
CY (1) CY1123801T1 (enExample)
DK (1) DK3458443T3 (enExample)
DO (1) DOP2018000241A (enExample)
EA (1) EA201892450A1 (enExample)
EC (1) ECSP18082774A (enExample)
ES (1) ES2829270T3 (enExample)
GE (1) GEP20217316B (enExample)
HR (1) HRP20201746T1 (enExample)
HU (1) HUE051348T2 (enExample)
IL (1) IL262580B (enExample)
JO (1) JOP20170107B1 (enExample)
LT (1) LT3458443T (enExample)
MA (1) MA45020B1 (enExample)
MX (1) MX382068B (enExample)
MY (1) MY187845A (enExample)
NI (1) NI201800116A (enExample)
PE (1) PE20190913A1 (enExample)
PH (1) PH12018502307A1 (enExample)
PL (1) PL3458443T3 (enExample)
PT (1) PT3458443T (enExample)
RS (1) RS61012B1 (enExample)
SA (1) SA518400371B1 (enExample)
SG (1) SG11201809126RA (enExample)
SI (1) SI3458443T1 (enExample)
SV (1) SV2018005778A (enExample)
TN (1) TN2018000369A1 (enExample)
TW (1) TWI723158B (enExample)
UA (1) UA122819C2 (enExample)
UY (1) UY37224A (enExample)
WO (1) WO2017191000A1 (enExample)
ZA (1) ZA201808130B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20217316B (en) * 2016-05-03 2021-11-10 Bayer Pharma AG Aromatic sulfonamide derivatives
ES2968172T3 (es) * 2016-10-24 2024-05-08 Fmc Corp Oxadiazoles que tienen actividad fungicida
WO2018104307A1 (en) * 2016-12-09 2018-06-14 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4
WO2018210729A1 (en) * 2017-05-18 2018-11-22 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives as antagonists or negative allosteric modulators of p2x4 receptor
JOP20190278A1 (ar) * 2017-05-31 2019-11-28 Novartis Ag مركبات 5، 6-ثنائية الحلقة مندمجة وتركيبات لعلاج الأمراض الطفيلية
CN111511720A (zh) * 2017-10-29 2020-08-07 拜耳股份公司 用于治疗缺血性中风的芳族磺酰胺衍生物
EP3844150A1 (en) 2018-08-31 2021-07-07 Xenon Pharmaceuticals Inc. Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents
JP7492005B2 (ja) * 2019-11-29 2024-05-28 武漢朗来科技発展有限公司 ベンゼン環含有化合物及びその応用
CN113082023B (zh) * 2019-12-23 2024-03-01 武汉朗来科技发展有限公司 P2x3抑制剂和p2x4抑制剂的药物组合及其应用
WO2021136238A1 (zh) * 2019-12-30 2021-07-08 武汉朗来科技发展有限公司 一种稠环化合物及其应用
WO2022002859A1 (en) 2020-06-30 2022-01-06 Bayer Aktiengesellschaft Substituted n-phenylacetamides having p2x4 receptor antagonistic activity
CA3188311A1 (en) 2020-06-30 2022-01-06 Bayer Aktiengesellschaft Use of n-phenylacetamides having p2x4 receptor antagonistic activity for treating certain ocular disorders
CN111743864B (zh) * 2020-08-05 2022-04-01 牡丹江医学院 一种体育外伤喷雾剂及其制备方法
WO2022049253A1 (en) 2020-09-07 2022-03-10 Bayer Aktiengesellschaft Substituted n-heteroaryl-n-pyridinylacetamides as p2x4 modulators
CN116635020A (zh) * 2021-01-27 2023-08-22 武汉朗来科技发展有限公司 一种芳香化合物、其制备方法及应用
EP4303214A4 (en) 2021-03-01 2025-02-19 Nihon Nohyaku Co., Ltd. CONDENSED HETEROCYCLIC COMPOUND HAVING A SULFONAMIDE GROUP OR SALT THEREOF, AGRICULTURAL/HORTICULTURAL PESTICIDE AND EXTERNAL OR INTERNAL ANIMAL PARASITE CONTAINING SAID COMPOUND OR SALT THEREOF, AND METHOD OF USING THE SAME
US20240239786A1 (en) * 2021-04-12 2024-07-18 Yale University Compositions and methods for the treatment and prevention of cancer
US11878269B2 (en) 2022-03-17 2024-01-23 International Business Machines Corporation Cyclopropeneimines for capture and transfer of carbon dioxide
US11975290B2 (en) 2022-03-17 2024-05-07 International Business Machines Corporation Cyclopropeneimines for capture and transfer of carbon dioxide
CA3246964A1 (en) * 2022-03-31 2025-07-09 Nippon Chemiphar Co., Ltd. PHARMACEUTICAL COMPOSITION FOR PREVENTING, SUPPRESSING OR TREATMENT OF A SYMPTOM ASSOCIATED WITH A PSEUDOALLEGIC REACTION
US12478951B2 (en) 2022-08-19 2025-11-25 International Business Machines Corporation Cyclopropenimines for activation of carbon dioxide
US12415889B2 (en) 2022-08-19 2025-09-16 International Business Machines Corporation Cyclopropenimines for activation of carbon dioxide
US12479793B2 (en) 2022-08-19 2025-11-25 International Business Machines Corporation Cyclopropenimines for mineralization of carbon dioxide
CN121175035A (zh) 2023-06-16 2025-12-19 武汉朗来科技发展有限公司 一种p2x4抑制剂固体分散体及其制备方法和应用
WO2025051851A1 (en) 2023-09-05 2025-03-13 Bayer Aktiengesellschaft Pharmaceutical dosage forms comprising 2-(2-chlorophenyl)-n-[4-(4-cyano-1h-pyrazol-1-yl)-3-sulfamoylphenyl]acetamide

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US5770615A (en) * 1996-04-04 1998-06-23 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5994398A (en) * 1996-12-11 1999-11-30 Elan Pharmaceuticals, Inc. Arylsulfonamides as phospholipase A2 inhibitors
HRP20161669T1 (hr) 2009-09-03 2017-02-24 Bristol-Myers Squibb Company Kinolini kao inhbitori kalijevih ionskih kanala
EP2552214A4 (en) 2010-03-26 2013-10-16 Glaxo Group Ltd PYRAZOLYL-PYRIMIDINES AS KINASE INHIBITORS
AU2011254242B2 (en) 2010-05-17 2015-10-29 Incozen Therapeutics Pvt. Ltd. Novel 3,5-disubstitued-3H-imidazo[4,5-b]pyridine and 3,5- disubstitued -3H-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
EP2597088B1 (en) 2010-07-13 2017-11-01 Nippon Chemiphar Co., Ltd. P2x4 receptor antagonist
KR102140746B1 (ko) 2012-01-13 2020-08-04 닛뽕 케미파 가부시키가이샤 P2x4 수용체 길항제
EP3010474A1 (en) * 2013-06-21 2016-04-27 L'oreal Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition
US10150744B2 (en) * 2013-07-12 2018-12-11 Nippon Chemiphar Co., Ltd P2X4 receptor antagonist
AU2014288116B2 (en) 2013-07-12 2018-05-17 Kyushu University P2X4 receptor antagonist
WO2015088564A1 (en) 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds
WO2015088565A1 (en) 2013-12-13 2015-06-18 Sunovion Pharmaceuticals Inc. P2x4 receptor modulating compounds and methods of use thereof
CA2988637A1 (en) * 2015-06-10 2016-12-15 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives
CN109414454A (zh) 2016-05-03 2019-03-01 加莱拉实验室有限责任公司 用于癌症治疗的组合疗法
GEP20217316B (en) 2016-05-03 2021-11-10 Bayer Pharma AG Aromatic sulfonamide derivatives
US9988367B2 (en) 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
WO2018104307A1 (en) * 2016-12-09 2018-06-14 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives and their use as anatagon i sts or negative allosteric modulators of p2x4
WO2018104305A1 (en) * 2016-12-09 2018-06-14 Bayer Pharma Aktiengesellschaft Field of application of the invention
WO2018210729A1 (en) * 2017-05-18 2018-11-22 Bayer Pharma Aktiengesellschaft Aromatic sulfonamide derivatives as antagonists or negative allosteric modulators of p2x4 receptor
CN111511720A (zh) * 2017-10-29 2020-08-07 拜耳股份公司 用于治疗缺血性中风的芳族磺酰胺衍生物

Similar Documents

Publication Publication Date Title
JP2019519484A5 (enExample)
HRP20201746T1 (hr) Aromatski derivati sulfonamida
JP5933902B2 (ja) Trkaキナーゼ阻害剤としてのピロリジニル尿素およびピロリジニルチオ尿素化合物
JP2019504821A5 (enExample)
JP2016523911A5 (enExample)
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
JP2017500364A5 (enExample)
US20090253676A1 (en) Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
JP2014527959A5 (enExample)
JP2014525444A5 (enExample)
JP2019530667A5 (enExample)
HRP20160539T1 (hr) Antagonisti trpv4
JP2018524331A5 (enExample)
ME02856B (me) Aminopirimidinilni spojevi kao inhibitori jak
JP2011518836A5 (enExample)
JP2015522002A5 (enExample)
JP2016510035A5 (enExample)
JP2014525448A5 (enExample)
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
JP2010510319A5 (enExample)
JP2017512794A5 (enExample)
RU2012146246A (ru) Антибактериальные производные изохинолин-3-илмочевины
JP2013522214A5 (enExample)
IL306126A (en) Heterocyclic compounds
HRP20200440T1 (hr) 1h-pirazolo[4,3-b]piridini kao pde1 inhibitori